Drug Information

General Information
Drug ID
DR00591
Drug Name
Chlorprothixene
Synonyms
(3E)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; (3E)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; (3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; (3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; (Z)-2-Chloro-9-(omega-dimethylaminopropylidene)thioxanthene; (Z)-2-Chloro-N,N-dimethylthioxanthene-.DELTA.(sup9),(sup.gamma.)-propylamine; (Z)-2-Chloro-N,N-dimethylthioxanthene-delta(sup 9,gamma)-propylamine; (alpha.-2-Chloro-9-.omega.-dimethylamino-propylamine)thioxanthene; 2-Chloro-9-[.omega.-(dimethylamino)propylidene]thioxanthene; 2-Chloro-9-[3-(dimethylamino)propylidene]thioxanthene; 2-Chloro-N,N-dimethylthioxanthene-.delta.(sup 9), .gamma.-propylamine; 3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethyl-1-propanamine; 3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; 3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; Alpha-Chlorprothixene; Chloroprothixene; Chlorprothixen; Chlorprothixene (JAN/USAN/INN); Chlorprothixene [USAN:INN:BAN:JAN]; Chlorprothixenum; Chlorprothixenum [INN-Latin]; Chlorprothixine; Chlorprotixen; Chlorprotixene; Chlorprotixine; Chlothixen; Cis-2-Chloro-9-(3-dimethylaminopropylidene)thioxanthene; Cis-Chlorprothixene; Clorprotisene; Clorprotisene [DCIT]; Clorprotixeno; Clorprotixeno [INN-Spanish]; Cloxan, Taractan, Truxal, Chlorprothixene; Iaractan; MK 184; N 714; N 714C; N-714; NCI56378; Paxyl; Rentovet; Ro 4-0403; Ro-4-0403;Trans(E)-Chlorprothixen; Tactaran; Taractan; Taractan (TN); Tarasan; Tardan; Thioxanthene-delta9,gamma-propylamine, 2-chloro-N,N-dimethyl-, (Z)-(8CI); Traquilan; Trictal; Truxal; Truxal (TN); Truxaletten; Truxil; Vetacalm; {3-[2-Chloro-thioxanthen-(9Z)-ylidene]-propyl}-dimethyl-amine
Drug Type
Small molecular drug
Therapeutic Class
Antipsychotic Agents
Structure
3D MOL 2D MOL
Formula
C18H18ClNS
Canonical SMILES
CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
InChI
InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-
InChIKey
WSPOMRSOLSGNFJ-AUWJEWJLSA-N
CAS Number
CAS 113-59-7
Pharmaceutical Properties Molecular Weight 315.9 Topological Polar Surface Area 28.5
Heavy Atom Count 21 Rotatable Bond Count 3
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2
XLogP
5.2
PubChem CID
667467
PubChem SID
10154 ,103237480 ,104098333 ,104253371 ,109612796 ,109839929 ,117740987 ,124634843 ,124757488 ,125141149 ,125164292 ,134338113 ,135692269 ,137171624 ,141696535 ,14950525 ,170507547 ,176484799 ,177749223 ,179038843 ,179116620 ,187072594 ,198936237 ,210279417 ,210281740 ,225203928 ,226471863 ,226471864 ,251911945 ,251915022 ,252219919 ,26665646 ,29217891 ,47424343 ,47869779 ,48318550 ,56394950 ,57408480 ,616473 ,74621737 ,7847855 ,81093297 ,81732 ,90534681 ,9276657
ChEBI ID
ChEBI:50931
TTD Drug ID
D0B0CP

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.